CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.59
-0.06 (-9.42%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +691.2% upside
Low Target $2.81
Average Target $4.68
High Target $5.27
Current Price $0.59
Current
$0.59
Target
$4.68
$2.81 $4.68 avg $5.27
Scenario Analysis
Bear Case
$2.81
375.1%
Low target
Base Case
$4.68
+691.2%
Avg target
Bull Case
$5.27
+791.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$29.80
-98.0% from high
52-Week Low
$0.33
+82.0% from low
Target vs 52W High
$4.68
-84.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%